Ciphergen Reports Q3 Revenue Jump | GenomeWeb

SAN DIEGO, Oct. 25 – Ciphergen Biosystems on Thursday posted third-quarter revenues of $5.4 million compared to $2.3 million for the same quarter a year ago, the company announced.

“This was a very strong quarter for Ciphergen, as our revenue growth accelerated and met plan,” William Rich, CEO of Ciphergen, said in a statement. “We believe that investment in our sales force and new product offerings are paying off, as well as the delivery of collaboration revenues through our Biomarker Centers.”

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: global genetic diversity map, and more.

The Nuffield Council on Bioethics identifies ethical questions to explore surrounding genome editing.

In a blog post, Brigham and Women's Hospital's Robert Green discusses "predispositional personal genome sequencing."

Stat News reports that there's muted opposition to the Kuwaiti DNA database law.